Ansa Biotechnologies
$46.5M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Ansa Biotechnologies is currently valued at $266.0M as of October 10, 2025. The company has raised a total of $129.2M in funding.
Capital Efficiency
With a capital efficiency ratio of 2.06x, Ansa Biotechnologies has achieved a valuation that is 2.06 times the total capital raised. This metric indicates moderate capital efficiency.
Investment Perspective
Ansa Biotechnologies's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Ansa Biotechnologies Worth in 2025?
As of 2025, Ansa Biotechnologies is valued at $266.0M, based on the company's Later Stage VC funding round in October 10, 2025. This valuation positions Ansa Biotechnologies as one of the leading private companies in the sector.
Ansa Biotechnologies Valuation History
Ansa Biotechnologies's funding history demonstrates steady growth and investor confidence.
How Ansa Biotechnologies Valuation is Determined
Private company valuations like Ansa Biotechnologies's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Ansa Biotechnologies Valuation FAQs
Is Ansa Biotechnologies profitable?
Ansa Biotechnologies has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Ansa Biotechnologies's valuation compare to competitors?
Ansa Biotechnologies is valued at $266.0M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Ansa Biotechnologies IPO?
Ansa Biotechnologies has not announced plans for an initial public offering. Until an IPO, investors can access Ansa Biotechnologies shares through secondary market platforms.